Cancer is currently ineffectively treated using therapeutic drugs, and is also able to resist
drug action, resulting in increased side effects following drug treatment. A novel therapeutic …

The peptide‐based therapeutic cancer vaccines have attracted enormous attention in recent
years as one of the effective treatments of tumour immunotherapy. Most of peptide‐based …

In ovarian cancer (OC), IL-17-producing T cells (Th17s) predict improved survival, whereas
regulatory T cells predict poorer survival. We previously developed a vaccine whereby …

Immunotherapy with checkpoint inhibitors has changed the paradigm of treatment for many
tumors, and endometrial carcinoma is not an exception. Approved treatment options are …

Cancer is a serious concern in public health worldwide. Numerous modalities including
surgery, radiotherapy, and chemotherapy, have been used for cancer therapies in clinic …

To date, surgery, chemotherapy and radiotherapy are mainly used to treat or remove
gynecological malignancies. However, these approaches have their limitations when facing …

Tumor immunotherapy has attracted more and more attention nowadays, and multiple
clinical trials have confirmed its effect in a variety of solid tumors. Immune checkpoint …

A glycosylphosphatidylinositol (GPI)-anchored glycoprotein called the folate receptor 1
(FOLR1) facilitates the transportation of folate by mediating receptor-mediated endocytosis …

Simple Summary Immunotherapy hinges on stimulating patients' immune system to fight
cancer. This treatment has led to improved survival in patients with malignancies such as …

Epithelial ovarian cancer (EOC) is the deadliest gynecological cancer, and presents a major
clinical challenge due to limited treatment options. Folate receptor alpha (FRα), encoded by …